Neopalytoxin
| Internal ID | 0874f569-8bae-4778-9f3e-06814cbab792 |
| Taxonomy | Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Glycosyl compounds > C-glycosyl compounds |
| IUPAC Name | 5-[(E,3R,4S)-5-[(2R,3R,4R,5S,6R)-6-[(1S,2R,3S,4S,5R,11S)-12-[(1R,3S,5S,7R)-5-[(8S)-9-[(2R,3R,4R,5R,6S)-6-[(E,2S,3S,6S,9R,10R)-10-[(2S,4R,5S,6R)-6-[(2R,3R)-4-[(2R,3S,4R,5R,6S)-6-[(2S,3Z,5E,8R,9S,10R,12Z,17S,18R,19R,20R)-21-[(2R,3R,4R,5S,6R)-6-[(Z,3R,4R)-5-[(1S,3R,5R,7R)-7-[2-[(2R,3R,5S)-5-(aminomethyl)-3-hydroxyoxolan-2-yl]ethyl]-2,6-dioxabicyclo[3.2.1]octan-3-yl]-3,4-dihydroxypent-1-enyl]-3,4,5-trihydroxyoxan-2-yl]-2,8,9,10,17,18,19-heptahydroxy-20-methyl-14-methylidenehenicosa-3,5,12-trienyl]-3,4,5-trihydroxyoxan-2-yl]-2,3-dihydroxybutyl]-4,5-dihydroxyoxan-2-yl]-2,6,9,10-tetrahydroxy-3-methyldec-4-enyl]-3,4,5,6-tetrahydroxyoxan-2-yl]-8-hydroxynonyl]-1,3-dimethyl-6,8-dioxabicyclo[3.2.1]octan-7-yl]-1,2,3,4,5-pentahydroxy-11-methyldodecyl]-3,4,5-trihydroxyoxan-2-yl]-3,4-dihydroxy-2-methylpent-1-enyl]-N-[(E)-3-(3-hydroxypropylamino)-3-oxoprop-1-enyl]-3-methyloxolane-2-carboxamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C129H221N3O53/c1-62(29-33-81(142)107(156)103(152)67(6)47-93-110(159)116(165)109(158)91(179-93)36-35-76(137)82(143)51-73-50-74-53-92(176-73)90(175-74)38-37-89-85(146)52-75(61-130)177-89)23-20-28-78(139)104(153)77(138)26-18-13-16-25-70(135)48-94-111(160)117(166)112(161)97(180-94)55-84(145)83(144)54-95-106(155)87(148)57-96(181-95)105(154)80(141)34-32-69(134)31-30-65(4)88(149)60-129(174)125(172)122(171)114(163)99(183-129)49-71(136)24-15-10-9-11-19-40-128-59-64(3)58-127(8,185-128)100(184-128)44-63(2)22-14-12-17-27-79(140)108(157)115(164)119(168)121(170)124-120(169)118(167)113(162)98(182-124)56-86(147)102(151)66(5)45-72-46-68(7)123(178-72)126(173)132-42-39-101(150)131-41-21-43-133/h13,16,18,20,23,25,30-31,35-36,39,42,45,63-65,67-100,102-125,133-149,151-172,174H,1,9-12,14-15,17,19,21-22,24,26-29,32-34,37-38,40-41,43-44,46-61,130H2,2-8H3,(H,131,150)(H,132,173)/b18-13+,23-20-,25-16-,31-30+,36-35-,42-39+,66-45+/t63-,64-,65-,67+,68?,69+,70+,71-,72?,73-,74+,75-,76+,77+,78+,79+,80+,81-,82+,83+,84+,85+,86-,87+,88-,89+,90+,91+,92-,93+,94-,95+,96-,97+,98+,99+,100+,102+,103+,104-,105+,106-,107+,108-,109+,110-,111-,112+,113-,114-,115-,116-,117+,118+,119+,120-,121-,122+,123?,124-,125+,127+,128-,129-/m0/s1 |
| InChI Key | RTVMXMYSQQSLGF-NGURBKPLSA-N |
| Popularity | 4 references in papers |
| Molecular Formula | C129H221N3O53 |
| Molecular Weight | 2662.10 g/mol |
| Exact Mass | 2661.4723837 g/mol |
| Topological Polar Surface Area (TPSA) | 995.00 Ų |
| XlogP | -5.60 |
| Atomic LogP (AlogP) | -7.59 |
| H-Bond Acceptor | 54 |
| H-Bond Donor | 43 |
| Rotatable Bonds | 77 |
| DTXSID801334022 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.7164 | 71.64% |
| Caco-2 | - | 0.8585 | 85.85% |
| Blood Brain Barrier | - | 0.8250 | 82.50% |
| Human oral bioavailability | - | 0.7286 | 72.86% |
| Subcellular localzation | Mitochondria | 0.5749 | 57.49% |
| OATP2B1 inhibitior | - | 0.8643 | 86.43% |
| OATP1B1 inhibitior | + | 0.7947 | 79.47% |
| OATP1B3 inhibitior | + | 0.9363 | 93.63% |
| MATE1 inhibitior | - | 0.9012 | 90.12% |
| OCT2 inhibitior | - | 0.9000 | 90.00% |
| BSEP inhibitior | + | 0.9525 | 95.25% |
| P-glycoprotein inhibitior | + | 0.7417 | 74.17% |
| P-glycoprotein substrate | + | 0.8658 | 86.58% |
| CYP3A4 substrate | + | 0.7670 | 76.70% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8639 | 86.39% |
| CYP3A4 inhibition | - | 0.9257 | 92.57% |
| CYP2C9 inhibition | - | 0.8665 | 86.65% |
| CYP2C19 inhibition | - | 0.8465 | 84.65% |
| CYP2D6 inhibition | - | 0.9186 | 91.86% |
| CYP1A2 inhibition | - | 0.8708 | 87.08% |
| CYP2C8 inhibition | + | 0.8826 | 88.26% |
| CYP inhibitory promiscuity | - | 0.9377 | 93.77% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.9600 | 96.00% |
| Carcinogenicity (trinary) | Non-required | 0.4815 | 48.15% |
| Eye corrosion | - | 0.9843 | 98.43% |
| Eye irritation | - | 0.8961 | 89.61% |
| Skin irritation | - | 0.7224 | 72.24% |
| Skin corrosion | - | 0.9172 | 91.72% |
| Ames mutagenesis | - | 0.5415 | 54.15% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7621 | 76.21% |
| Micronuclear | + | 0.6900 | 69.00% |
| Hepatotoxicity | + | 0.5011 | 50.11% |
| skin sensitisation | - | 0.8313 | 83.13% |
| Respiratory toxicity | + | 0.7778 | 77.78% |
| Reproductive toxicity | + | 0.9667 | 96.67% |
| Mitochondrial toxicity | + | 0.9625 | 96.25% |
| Nephrotoxicity | + | 0.5782 | 57.82% |
| Acute Oral Toxicity (c) | III | 0.5955 | 59.55% |
| Estrogen receptor binding | + | 0.7057 | 70.57% |
| Androgen receptor binding | + | 0.7731 | 77.31% |
| Thyroid receptor binding | + | 0.7138 | 71.38% |
| Glucocorticoid receptor binding | + | 0.8057 | 80.57% |
| Aromatase binding | + | 0.6971 | 69.71% |
| PPAR gamma | + | 0.8183 | 81.83% |
| Honey bee toxicity | - | 0.5821 | 58.21% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | - | 0.6200 | 62.00% |
| Fish aquatic toxicity | + | 0.8797 | 87.97% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.55% | 91.11% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 99.53% | 95.92% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 98.14% | 94.75% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 97.94% | 90.17% |
| CHEMBL2581 | P07339 | Cathepsin D | 97.91% | 98.95% |
| CHEMBL204 | P00734 | Thrombin | 97.61% | 96.01% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.42% | 96.09% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 97.07% | 97.29% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 96.71% | 97.21% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.26% | 97.09% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 96.24% | 100.00% |
| CHEMBL3401 | O75469 | Pregnane X receptor | 95.97% | 94.73% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 94.79% | 99.17% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 94.66% | 100.00% |
| CHEMBL2563 | Q9UQL6 | Histone deacetylase 5 | 94.52% | 89.67% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 94.34% | 96.95% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 93.48% | 98.75% |
| CHEMBL1829 | O15379 | Histone deacetylase 3 | 93.00% | 95.00% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 92.76% | 90.08% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 92.65% | 95.71% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 92.10% | 98.33% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 92.05% | 95.93% |
| CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 91.44% | 91.24% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.16% | 96.47% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 91.01% | 86.33% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 90.95% | 93.56% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 90.70% | 83.82% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 90.69% | 89.34% |
| CHEMBL2964 | P36507 | Dual specificity mitogen-activated protein kinase kinase 2 | 90.51% | 80.00% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 89.76% | 96.00% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 89.67% | 89.00% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 89.07% | 96.90% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 87.68% | 97.14% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 87.42% | 91.19% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 87.20% | 93.10% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 86.95% | 92.32% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 86.75% | 96.00% |
| CHEMBL1994 | P08235 | Mineralocorticoid receptor | 86.25% | 100.00% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 85.78% | 85.31% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 85.50% | 98.03% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 85.49% | 93.18% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 84.65% | 95.89% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 84.64% | 98.05% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 84.59% | 94.00% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 84.49% | 99.23% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 84.29% | 100.00% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 84.24% | 94.45% |
| CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 84.11% | 91.07% |
| CHEMBL2716 | Q8WUI4 | Histone deacetylase 7 | 83.84% | 89.44% |
| CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 83.70% | 94.50% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 83.67% | 88.56% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 83.67% | 96.33% |
| CHEMBL5678 | P34947 | G protein-coupled receptor kinase 5 | 83.62% | 88.00% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 83.46% | 97.25% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 83.38% | 97.79% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 83.22% | 92.86% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 83.17% | 95.50% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 82.64% | 95.56% |
| CHEMBL5028 | O14672 | ADAM10 | 82.58% | 97.50% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 82.23% | 95.89% |
| CHEMBL5255 | O00206 | Toll-like receptor 4 | 82.15% | 92.50% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 82.05% | 95.50% |
| CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 81.87% | 97.33% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 81.56% | 95.00% |
| CHEMBL4246 | P42680 | Tyrosine-protein kinase TEC | 80.57% | 82.05% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 146684854 |
| LOTUS | LTS0175786 |
| wikiData | Q105245448 |